Determination of RBC membrane and serum lipid composition in trinidadian type II diabetics with and without nephropathy

Vascular Health and Risk Management

Volumn 4, Issue 4, 2008, Pages 893-899

  Nayak, B Shivananda ^a   Beharry, Vishi Y ^a   Armoogam, Shivani ^a   Nancoo, Melinda ^a   Ramadhin, Kevin ^a   Ramesar, Kiron ^a   Ramnarine, Ciara ^a   Singh, Anandi ^a   Singh, Anisha ^a   Nwachi, Kingsley Uche ^a   Teelucksing, Surujpaul ^b   Mathura, Ramesh ^c   Roberts, Lesley ^c  

^a EWMSC   (Trinidad and Tobago)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^c NCRHA   (Trinidad and Tobago)

Author keywords

Diabetes; Diabetic nephropathy; Phospholipids; Protein; RBC membrane

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DIET RESTRICTION; DIETARY INTAKE; EARLY DIAGNOSIS; ERYTHROCYTE MEMBRANE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LIFESTYLE; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; SYSTOLIC BLOOD PRESSURE; TRINIDAD AND TOBAGO; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIET; ERYTHROCYTE MEMBRANE; HUMANS; LIFE STYLE; MEMBRANE LIPIDS; MIDDLE AGED; PHOSPHOLIPIDS; RISK REDUCTION BEHAVIOR; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRINIDAD AND TOBAGO; WAIST-HIP RATIO; YOUNG ADULT;

EID: 52249094151     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barcelo A, Rajpathak S. 2001. Incidence and Prevalence of diabetes mellitus in the Americas. Pan Am J Public Health, 10:300-8.
2. Ballas SK, Krasnow SH. 1980. Structure of erythrocyte membrane and its transport functions. Ann Clin Lab Sci, 10:209-19.
3. Bakan E, Yildirim A, Kurtul N, et al. 2006. Effects of type 2 diabetes mellitus on plasma fatty acid composition and cholesterol content of erythrocyte and leukocyte membranes. Acta Diabetologica, 43:109-13.
4. Bonting SL. 1970. In: Bilter EE (ed). Membrane and ion transport. London; Wiley Interscience, Vol. 1, p. 257.
5. Boyne M, Carter A, Doobay R, et al. 2006. The Caribbean Health Research Council Guidelines for Managing Diabetes in Primary Care in the Caribbean. 2nd edition. Caribbean Health Research Council.
6. Bryszewska M, Watala C, Torzecka W. 1986. Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes. Br J Haematol, 62:111-16.
7. Lee C-YJ, Kim K-C, Park H-W, et al. 2004. Rheological properties of erythrocytes from male hypercholesterolemia. Microvasc Res, 67:133-8.
8. Ellenberg M, Rifkin H. 1983. Diabetes Mellitus Theory and Practice. 3rd ed. New York: Medical Examination Publishing Co.
9. Folch JM, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem, 226:497-509.
10. Garnier M, Attali JR, Valensi P, et al. 1990. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism, 39:794-8.
11. Kumar V, Cotran R, Robbins S. 2003. Robbins Basic Pathology. 7th edition. Philadelphia: Saunders.
12. Lowry OH, Rosebrough NJ, Farr AL, et al. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem, 193:265-75.
13. Miossec PF, Zkhiri J, Pariès M, et al. 1999. Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients; Diabet Med, 16:424-30.
14. Nagle JF, Tristram-Nagle S. 2000. Structure of lipid bilayers. Biochim Biophys Acta, 1469:159-95.
15. Parekh AL, Jung DH. 1970. Cholesterol determination with ferric acetate - uranium. Anal Chem, 42:1423.
16. Prisco D, Paniccia R, Coppo M, et al. 1989. Red blood cell lipid alteration in type II diabetes mellitus. Thromb Res, 54:751-8.
17. Rouser G, Fleischer S, Yamamoto A. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids, 5:494-6.
18. Sampietro T, Lenzi S, Cecchetti P, et al. 1986. Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. Clin Chem, 32:1328-31.
19. Stedman's (ed). 2005. Stedman's Medical Dictionary for the Health Professional and Nursing. 5th ed. Baltimore: Lippincott, Williams and Wilkins.
20. Talwar G, Srivastava L. 2003. Textbook of Biochemistry and Human Biology. New Delhi: Prentice Hall of India.
21. Valabhji J, Elkeles R. 2003. Dyslipidemia in type 2 diabetes: Epidemiology and biochemistry. Br J Diabetes Vasc Dis, 3:184-9.
22. Watala C, Pluta J, Golanski J, et al. 2005. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med, 83:148-58.
23. Watała C. 1988. In vitro glycation of red blood cell proteins: high levels of glucose lower lipid fluidity of erythrocyte membranes. Exp Pathol, 33:233-8.
24. [WHO] World Health Organization. 2007. What is diabetes? (updated 2006) [online]. Accessed on November 14, 2007. URL: http://www.who.int/ mediacentre/factsheets/fs312/en/index.html.